Melanoma Screening Summit Header

The ASSC Melanoma Screening Summit was held in Brisbane on Monday 25 March, 2019. Hosting over 150 registered delegates, the Summit aimed to develop a road map for reducing melanoma mortality in Australia through evaluation of new opportunities in early detection.

The invited speakers gave an overview of the current evidence, emerging trends and dilemmas with respect to the early detection of melanoma, and many of the presentations have been made available.

Principles of screening and how it applies to melanoma Professor David Whiteman

QIMR Berghofer Medical Research Institute

Over-diagnosis of melanoma Dr Katy Bell

University of Sydney

Feasibility of population vs targeted screening Professor Peter Baade

Cancer Council Queensland

Health economics of melanoma detection, diagnosis & treatment Associate Professor Louisa Gordon

QIMR Berghofer Medical Research Institute

Some contributions to the evidence from Australia Professor Joanne Aitken

Cancer Council Queensland

International perspective on melanoma screening Professor Alexander Katalinic

University of Luebeck, Germany

Clinical Perspective: Acceptable absolutes and what to do with all the keratinocyte cancers Professor Scott Menzies

University of Sydney

The role of whole body imaging & the opportunity for screening Professor H. Peter Soyer

The University of Queensland

Impacts of AI and new technology for detection Professor Susan Swetter

Stanford University, USA

Is pathology the gold standard for melanoma diagnosis Professor Richard Scolyer

Melanoma Institute Australia

A population-based screening program versus opportunistic screening and early detection Professor Sancy Leachman,

Oregon Health & Science University, USA

National requirements for the government to consider a screening program Dr Jeanette Young

Queensland Government